% of patients seeing effects from day one and up to 75% of patients maintaining improvements for six months.41-43Relfydess is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.44,45It was entirely created and manufactured by Galderma to expand its neuromodulator portfolio as part of the broadest Injectable Aesthetics portfolio on the market. Relfydess has received a marketing authorization in many markets. Authorization conditions vary internationally.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the h
=*=*=*=*=*=
当前为第10/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页